Public Board of Directors papers 27.01.22

SP noted that to deliver the required level of mutual aid we asked what staff we would need, this is what is in the budget. For budget setting for next year we will review all of this and may take some of these out. GP asked about high patient satisfaction but asked what we do with any poor responses. BD noted that we pick these up through incidents, complaints etc and work closely with the Quality & Standards team to respond. GP asked about the underspends and if we will have a surplus what do we do. SP noted that money is coming in with little notice so it is difficult to plan, we can reallocate at year end across the system. GP asked about the higher sickness rates in estates & facilities and whether this gets additional attention. EL noted that we know what the hotspots are and we are working with these areas with higher levels and this is managed closely with the HR team. JY noted that all patient experience and safety data is well scrutinised at Quality Assurance Committee. CO congratulated the team on the improving position on waiting times that is a massive effort. No further comments or questions raised. Report noted. c Medical directors report – School of Oncology update CH introduced RF as the new Director of Education and CHv as Associate Director of Education. RF introduced himself, he is from an academic education background. RF thanked Richard Cowan for his work so far and noted the success of the team over the pandemic. CHv noted the student placements activities. There is a push to increase the number we train due to shortages going forward. We have done this through a virtual radiotherapy placement for protons which has been well evaluated and award winning. We have been funded by Health Education England to allow a 1 or 2 week virtual placement for therapy radiography students in protons and radiotherapy. This will be broadened to over 1500 students. We have introduced a new practice educator in SACT delivery. We have specialist leads on this work alongside the University of Manchester and the School of Oncology on a SACT module to teach others how to effectively deliver chemotherapy, this will be opened up nationally and then internationally. Our education offerings relating to the PET-CT and Gateway-C training have been very successful virtually, the numbers of people using these are very impressive. The events team have converted over 80% of our education to purely virtual, the remaining 20% is highbred. They have doubled the numbers that are accessing the courses & events offered. Internationally we are supporting work in Kenya, China and Nigeria and this work is now funding a Fellow post to come and learn here. RF reflected that there’s a huge amount of energy to develop education. This is mainly about education for Christie colleagues to deliver excellent care, it is about the GM ICS and how education is supported across the system. We are also looking at education for all staff including non-clinical. Patient and public involvement (PPI) and patient education is also included. The School is recognising academic achievement but looking at outputs and

6